These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 17415999

  • 1. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
    Cao Q, Feng YJ.
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999
    [Abstract] [Full Text] [Related]

  • 2. Phosphorylation of glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells.
    Cai G, Wang J, Xin X, Ke Z, Luo J.
    Int J Oncol; 2007 Sep; 31(3):657-62. PubMed ID: 17671694
    [Abstract] [Full Text] [Related]

  • 3. Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells.
    Cao Q, Lu X, Feng YJ.
    Cell Res; 2006 Jul; 16(7):671-7. PubMed ID: 16788573
    [Abstract] [Full Text] [Related]

  • 4. Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer.
    Cho YJ, Yoon J, Ko YS, Kim SY, Cho SJ, Kim WH, Park JW, Youn HD, Kim JH, Lee BL.
    APMIS; 2010 Oct; 118(10):782-90. PubMed ID: 20854473
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
    Xia YX, Lu L, Wu ZS, Pu LY, Sun BC, Wang XH.
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
    [Abstract] [Full Text] [Related]

  • 6. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
    Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H.
    Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.
    Sun J, Yan P, Chen Y, Chen Y, Yang J, Xu G, Mao H, Qiu Y.
    Diagn Pathol; 2015 Jun 19; 10():72. PubMed ID: 26088648
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.
    Wang WC, Kuo CY, Tzang BS, Chen HM, Kao SH.
    J Cell Biochem; 2012 Nov 19; 113(11):3567-75. PubMed ID: 22740511
    [Abstract] [Full Text] [Related]

  • 15. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
    Nemoto T, Kanai T, Yanagita T, Satoh S, Maruta T, Yoshikawa N, Kobayashi H, Wada A.
    Eur J Pharmacol; 2008 May 31; 586(1-3):82-9. PubMed ID: 18395711
    [Abstract] [Full Text] [Related]

  • 16. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y, Yang J, Gao Y, Zhao XL, Li HZ, Yao Z.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul 31; 44(7):522-8. PubMed ID: 19957553
    [Abstract] [Full Text] [Related]

  • 17. Serine 9 and tyrosine 216 phosphorylation of GSK-3β differentially regulates autophagy in acquired cadmium resistance.
    Park CH, Lee BH, Ahn SG, Yoon JH, Oh SH.
    Toxicol Sci; 2013 Oct 31; 135(2):380-9. PubMed ID: 23897984
    [Abstract] [Full Text] [Related]

  • 18. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
    Hongisto V, Vainio JC, Thompson R, Courtney MJ, Coffey ET.
    Mol Cell Biol; 2008 Mar 31; 28(5):1515-27. PubMed ID: 18195042
    [Abstract] [Full Text] [Related]

  • 19. Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer.
    Chen S, Sun KX, Feng MX, Sang XB, Liu BL, Zhao Y.
    Drug Des Devel Ther; 2016 Mar 31; 10():1225-32. PubMed ID: 27051274
    [Abstract] [Full Text] [Related]

  • 20. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
    Neelam S, Brooks MM, Cammarata PR.
    Mol Vis; 2014 Mar 31; 20():1758-75. PubMed ID: 25593505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.